Target Name: MIR23B
NCBI ID: G407011
Review Report on MIR23B Target / Biomarker Content of Review Report on MIR23B Target / Biomarker
MIR23B
Other Name(s): microRNA 23b | MiRNA23B | miRNA23B | hsa-miR-23b-5p | hsa-miR-23b-3p | mir-23b | MIRN23B | MicroRNA 23b | hsa-mir-23b

miRNA 23b: A Non-coding RNA Molecule with Potential Drug Targets Or Biomarkers

MicroRNA (miRNA) 23b is a non-coding RNA molecule that plays a crucial role in regulating various cellular processes in the human body. It is a small RNA molecule that contains about 20-22nt of sequence length. MiRNA 23b is expressed in various cell types of the human body, including blood cells, liver cells, and epithelial cells. The primary function of miRNA 23b is to target specific mRNAs for degradation by the 21st century RNA-protein complex.

One of the unique features of miRNA 23b is its ability to interact with multiple target RNAs. It can interact with miR-18a, miR-18b, miR-20b, and miR-21, among others. This interaction with other miRNAs makes miRNA 23b a potential drug target or biomarker. The targets of miRNA 23b can be different depending on the cell type and the context in which it is expressed.

miRNA 23b has been shown to play a role in various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to regulate the expression of genes involved in cell adhesion, migration, and invasion. It has also been shown to play a role in the regulation of cell cycle progression and the apoptosis that follows it.

One of the most significant functions of miRNA 23b is its role in cell apoptosis. Apoptosis is a natural process that is essential for the development and maintenance of multicellular organisms. It is a process in which cells undergo programmed cell death, which is regulated by various signaling pathways. MiRNA 23b has been shown to play a role in the regulation of apoptosis in various cell types of the human body.

Studies have shown that miRNA 23b can induce apoptosis in various cell types, including cancer cells. For example, a study by Zhao et al. (2014) found that miRNA 23b was upregulated in various human cancer tissues and was associated with the development of cancer. This suggests that miRNA 23b may be a potential drug target or biomarker for cancer.

Another function of miRNA 23b is its role in cell signaling pathways. miRNA 23b has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the PI3K/Akt signaling pathway. The TGF-β pathway is involved in the regulation of cell growth, differentiation, and apoptosis, while the PI3K/Akt signaling pathway is involved in the regulation of cell signaling pathways.

Studies have shown that miRNA 23b can regulate the expression of genes involved in these pathways. For example, a study by Wang et al. (2014) found that miRNA 23b was involved in the regulation of the expression of genes involved in the TGF-β pathway. This suggests that miRNA 23b may be a potential drug target or biomarker for TGF-β-related diseases.

In addition to its role in cell signaling pathways, miRNA 23b has also been shown to play a role in the regulation of cell adhesion. Adhesion is an essential process that is involved in the regulation of cell behavior and interactions. MiRNA 23b has been shown to play a role in the regulation of cell adhesion in various cell types of the human body.

Studies have shown that miRNA 23b can regulate the expression of genes involved in cell adhesion. For example, a study by Liu et al. (2014) found that miRNA 23b was involved in the regulation of the expression of genes involved in cell adhesion. This suggests that miRNA 23b may be a potential drug target or biomarker for diseases associated with

Protein Name: MicroRNA 23b

The "MIR23B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR23B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1